Jazz Pharmaceuticals (JAZZ) PT Raised to $175 at Deutsche Bank
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Jazz Pharmaceuticals (JAZZ) PT Raised to $182 at Wells Fargo
May 15, 2018 2:01 PM EDTWells Fargo raised its price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $182.00 (from $176.00) while maintaining an Outperform rating following Q1 results.
Analyst David Maris notes their 2018 EPS estimate is now $13.00 (vs prior $12.91).
... More